GlassScriptPhysician profile
Ali Qadri
NPI 1790368538
$16,529.39
in general payments reported to CMS, 2019-2025
7 companies · $6,156 in 2025
The $6,156 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $10K · 2025: $6,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $4,793 · Food and Beverage: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $4,793.29 |
| Food and Beverage | $1,736.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,392.23 | 2024-2025 | |
| Paragon 28, INC. | $2,276.16 | 2025 | Portfolio, Bun-Yo-Matic, Monkey Rings |
| Stryker Corporation | $1,852.53 | 2025 | Hoffmann, Prostep Mica, Inbone |
| Integra Lifesciences Corporation | $731.45 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aroa Biosurgery Incorporated | $179.00 | 2024 | |
| Treace Medical Concepts, INC. | $80.19 | 2025 | |
| Linvatec Corporation | $17.83 | 2025 | Ibs, Biobrace 23mm, Hercules Suture Anchor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Qadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.